Induction of tolerance to skin homografts with a methylhydrazine derivative. Synergism with antilymphocytic serum and morphologic responses of the lymphoid system.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004357:Drug Synergism; D005260:Female; D006084:Graft Rejection; D006834:Hydrazines / Q000008:administration & dosage / Q000494:pharmacology*; D007165:Immunosuppression Therapy; D007279:Injections, Subcutaneous; D008221:Lymphoid Tissue / Q000166:cytology* / Q000187:drug effects; D051379:Mice; D016038:Skin Transplantation; D013154:Spleen / Q000166:cytology; D013934:Thymectomy; D013950:Thymus Gland / Q000166:cytology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014508:Urea / Q000008:administration & dosage
D000961:Antilymphocyte Serum; D001593:Benzyl Compounds; D006834:Hydrazines; D003520:Cyclophosphamide; D014508:Urea